Dozodox 50 Dry Syrup contains Cefpodoxime Proxetil 50mg/5ml, a third-generation cephalosporin antibiotic widely prescribed in pediatric practice. It helps in the treatment of bacterial infections affecting the respiratory tract, ENT, urinary tract, skin, and soft tissues in children.
Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, leading to the elimination of susceptible bacteria. Its broad-spectrum activity and favorable safety profile make it a preferred choice for pediatric bacterial infections requiring oral antibiotic therapy.
This dry syrup formulation ensures accurate dosing, good palatability, and improved compliance among children. Dozodox 50 Dry Syrup is commonly recommended by pediatricians and physicians for mild to moderate infections, making it a consistent-demand product across clinics and hospitals.
Adding Dozodox 50 Dry Syrup to your pediatric antibiotic segment strengthens your pharmaceutical portfolio with a trusted cephalosporin therapy. Its widespread prescriber acceptance, regular prescription flow, and suitability for domestic as well as export markets make it a valuable product for distributors and healthcare suppliers.